Titanium Healthcare, Inc. Receivables Turnover Ratio (TIHC), from the third quarter 2015 to the third quarter 2014 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Titanium Healthcare, Inc.  (TIHC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Titanium Healthcare Accounts Receivables Turnover Ratio from the third quarter 2015 to the third quarter 2014

Quarterly Results, Trends, Rankings, Statistics


Titanium Healthcare, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2015 to a ratio of 9.82, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the third quarter 2015. Average receivable collection period, for the Titanium Healthcare in Sep 30 2015 quarter, has decreased to 37 days, compared to 42 days, in the Jun 30 2015 quarter.

If we take a look into Healthcare sector 7 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 230, from overall ranking in the second quarter 2015 at 1458.

What is Receivable Turnover Ratio?
What is Titanium Healthcare, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TIHC Receivables Turnover Ratio (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Receivable Change -18.66 % - - - -
Y / Y Revenue Change 11406.33 % - - - -
Receivable Turnover Ratio (TTM) 9.82 8.71 7.01 3.87 0.02
TIHC's Total Ranking # 230 # 1458 # 0 # 0 # 0
Accounts Receivable average collection period days 37 42 52 94 18888
Seq. Receivable Change -31.71 % 53.91 % 13.69 % -31.92 % -
Seq. Revenue Change -84.73 % 35.95 % 65.08 % 33467.83 % -


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 8
Overall Market # 230

Receivable Turnover Ratio Statistics
High Average Low
2.55 2.3 2.05
(Sep 30 2015)   (Jun 30 2015)





TIHC Company Profile • Back to TIHC Efficiency Comparisons • Compare TIHC Receivables Turnover Ratio to its Competitors

Financial Statements
Titanium Healthcare's Accounts Receivable $ 0 Millions Visit TIHC's Balance sheet
Titanium Healthcare's Sales TTM $ 2 Millions Visit TIHC's Income Statement
Sources of TIHC's Revenues Visit TIHC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TIHC's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TIHC's Growth Rates TIHC's Roa TIHC's Inventory Turnover Ratio TIHC's Dividend Comparisons
TIHC's Profitability Ratios TIHC's Roi TIHC's Asset Turnover Ratio TIHC's Dividend Growth
TIHC's Valuation Ratios TIHC's Roe TIHC's Financial Strength Ratios TIHC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2015, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2015 Receivable at quarter ending Sep 30 2015
Cyteir Therapeutics Inc   26.91 $ 2,005.300  Millions$ 74.525  Millions
Regeneron Pharmaceuticals Inc   25.48 $ 3,807.980  Millions$ 149.444  Millions
Ernexa Therapeutics Inc   25.02 $ 24.748  Millions$ 0.989  Millions
U s Stem Cell Inc   24.79 $ 2.269  Millions$ 0.092  Millions
Skinvisible Inc   24.47 $ 0.172  Millions$ 0.007  Millions
Aspira Women s Health inc   24.18 $ 3.385  Millions$ 0.140  Millions
Immunogen inc   22.12 $ 87.189  Millions$ 3.941  Millions
Lumos Pharma Inc   21.99 $ 230.094  Millions$ 10.463  Millions
Microbot Medical Inc   21.34 $ 0.971  Millions$ 0.046  Millions
Pfenex Inc   21.06 $ 8.341  Millions$ 0.396  Millions
Glucotrack Inc   20.58 $ 0.386  Millions$ 0.019  Millions
First Choice Healthcare Solutions Inc   20.26 $ 44.006  Millions$ 2.172  Millions
Cti Biopharma Corp   19.70 $ 22.581  Millions$ 1.146  Millions
Biocept Inc   18.95 $ 0.467  Millions$ 0.025  Millions
Rigel Pharmaceuticals Inc  17.97 $ 28.608  Millions$ 1.592  Millions
Enanta Pharmaceuticals Inc  17.97 $ 160.880  Millions$ 8.955  Millions
Agios Pharmaceuticals Inc   17.80 $ 67.537  Millions$ 3.795  Millions
Pacific Biosciences Of California Inc   17.47 $ 73.405  Millions$ 4.202  Millions
Cyclo Therapeutics Inc   17.39 $ 1.234  Millions$ 0.071  Millions
Vystar Corporation  16.57 $ 0.470  Millions$ 0.028  Millions
Alaunos Therapeutics Inc   16.56 $ 2.753  Millions$ 0.166  Millions
Coherus Oncology inc   16.39 $ 26.336  Millions$ 1.607  Millions
Ethema Health Corporation   16.35 $ 1.916  Millions$ 0.117  Millions
International Stem Cell Corporation  15.85 $ 7.390  Millions$ 0.466  Millions
Halozyme Therapeutics Inc   15.78 $ 138.065  Millions$ 8.751  Millions
Pacira Biosciences inc   15.55 $ 377.345  Millions$ 24.269  Millions
Processa Pharmaceuticals Inc   15.50 $ 0.139  Millions$ 0.009  Millions
Acorda Therapeutics Inc   15.43 $ 479.629  Millions$ 31.079  Millions
Harrow Inc   15.05 $ 6.763  Millions$ 0.449  Millions
Veracyte Inc   14.99 $ 47.660  Millions$ 3.180  Millions

Date modified: 2026-09-18T13:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.